Sotac Pharmaceuticals Limited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

Sotac Pharmaceuticals Limited has submitted a compliance certificate to the stock exchange for the quarter ending September 30, 2026. This document confirms that the company has fulfilled its obligations under the SEBI (Depositories and Participants) Regulations, 2018. The filing is a routine administrative requirement designed to ensure transparency and proper compliance with market regulations.

For investors, this news is generally neutral and does not indicate any operational changes or financial results. It serves as a standard update from the company's management regarding its adherence to corporate governance norms. While it does not provide specific insights into the company's business performance, it confirms that the company is maintaining its regulatory filings on schedule.

Investors should continue to monitor the company's future quarterly results and operational updates for more relevant information. This filing is a procedural step and should not be viewed as a signal for immediate price movement. Keeping an eye on the company's earnings reports will likely provide more actionable insights for your investment decisions.